Pathology & Disease Progression studies
Syllabus Unit: Pre & Para Clinical Subjects
Why it matters
Chapter overview
Pathology links cellular-level mechanism to bedside pattern recognition — how reversible cell injury becomes irreversible necrosis, how a normal cell acquires the hallmarks of cancer, how a CBC and coagulation panel localise a blood disorder, and how a single pathognomonic lesion (Ghon complex, Aschoff body, Reed-Sternberg cell) identifies an entire disease — and AIIMS PG tests this pattern-recognition skill relentlessly through classic named findings.
1Cell Injury, Inflammation & Repair
Reversible cell injury, the cardinal signs of acute inflammation, and the phases of wound repair form pathology's foundational cause-and-effect chain from insult to outcome.
Learning Objectives
- Distinguish reversible cell injury from irreversible injury (necrosis) and their key markers.
- Name the patterns of necrosis with a classic example of each.
- Sequence the vascular and cellular events of acute inflammation.
- Differentiate the chemical mediators of inflammation by their principal effect.
Key Terms
Cell injury and inflammation questions test pattern matching: given a described necrosis pattern or inflammatory event, identify the exact named process and the clinical scenario it points to.
Patterns of necrosis
- Coagulative — ischaemic infarcts of solid organs (except brain); architecture preserved.
- Liquefactive — brain infarcts, bacterial abscesses; tissue liquefies.
- Caseous — tuberculosis; cheese-like, combines both patterns.
- Fat necrosis — acute pancreatitis (enzymatic) or trauma to fatty tissue.
- Fibrinoid necrosis — immune-mediated vessel wall damage (vasculitis, malignant hypertension).
- Gangrenous necrosis — ischaemic limb necrosis, may be dry (coagulative) or wet (with superimposed infection, liquefactive).
Acute inflammation
Chemical mediators
Histamine (from mast cells) causes immediate vasodilation and permeability; prostaglandins (via the COX pathway, the target of NSAIDs) cause vasodilation, pain and fever; leukotrienes (LTB4 for chemotaxis, LTC4/D4/E4 for bronchoconstriction) are targeted by drugs like montelukast; complement (C3a/C5a, C5a chemotaxis, C3b opsonisation) links innate and adaptive immunity.